Related Experiment Video
Updated: Jul 16, 2026

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft
Published on: September 15, 2023
Leukodepletion improves renal function in patients with renal dysfunction undergoing on-pump coronary bypass surgery:
1Department of Cardiovascular Surgery, Gülhane Military Medical Academy, Ankara, Turkey.
Insights
Leukodepletion may protect kidney function in patients undergoing on-pump coronary artery bypass grafting (CABG) surgery. This method reduced markers of renal injury and the need for dialysis in patients with existing renal dysfunction.
Area of Science:
- Cardiology
- Nephrology
- Transfusion Medicine
Background:
- On-pump coronary artery bypass grafting (CABG) can impact renal function.
- Leukodepletion is a technique used during blood transfusions.
Purpose of the Study:
- To evaluate the effect of leukodepletion on renal function in patients undergoing on-pump CABG.
- To assess if leukodepletion can prevent renal impairment and tubular damage.
Main Methods:
- Fifty patients with normal preoperative cardiac function and mild renal dysfunction were randomized into two groups.
- Group A (n=25) underwent on-pump CABG with leukodepletion; Group B (n=25) underwent on-pump CABG without leukodepletion.
- Renal injury was assessed using plasma creatinine, blood urea nitrogen (BUN), and urinary alpha glutathione S-transferase (GST).
Main Results:
- The leukodepletion group showed decreased levels of creatinine, BUN, and urinary GST post-surgery compared to the control group.
- No mortality was observed in either group.
- Three patients in the control group required postoperative dialysis, while none in the leukodepletion group did.
Conclusions:
- Leukodepletion appears beneficial in preventing renal impairment and tubular damage in patients with renal dysfunction undergoing on-pump CABG.
- The findings suggest leukodepletion is a valuable strategy to preserve kidney function in this patient population.
Background:
We aimed to show the impact of leukodepletion on renal function in patients undergoing on-pump coronary revascularization.
Patients And Methods:
Fifty patients awaiting elective on-pump coronary revascularization with normal preoperative cardiac functions and with plasma creatinine levels ranging between 1.5 and 2.0 mg/dL were prospectively randomized into two groups: on-pump CABG with (group A: n = 25) and without leukodepletion (group B, n = 25). Renal glomerular and tubular injury were assessed by urinary alpha glutathione s-transferase (GST), plasma creatinine, and blood urea nitrogen (BUN) levels.
Results:
The patients consisted of 14 females and 36 males with a mean age of 57.6 +/- 5.3 years. In the leukodepletion group, the mean levels of creatinine, BUN and urinary GST were found to be decreased on the first, third and fifth postoperative days compared with the control group. There was no mortality. Three patients in the control group needed postoperative dialysis.
Conclusion:
Patients with renal dysfunction undergoing on-pump CABG surgery seem to benefit from leukodepletion as a measure to prevent tubular damage and renal impairment compared with a control group.
Related Concept Videos
Heart Failure Drugs: Diuretics
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Hemodialysis II: Procedure and Complications
